Insider Trading & Ownership of William R. Jellison

Location
Avon Lake, OH
Summary
The estimated net worth of William R. Jellison is at least $3,742,280 dollars as of 29 Apr 2026. William R. Jellison is the Director of AVIENT CORP and owns shares of AVIENT CORP (AVNT) stock worth about $2.18M. William R. Jellison is the Director of MASIMO CORP and owns shares of MASIMO CORP (MASI) stock worth about $740.5K. William R. Jellison is the Director of Medtronic plc and owns shares of Medtronic plc (MDT) stock worth about $558.4K. William R. Jellison is the Director of Anika Therapeutics, Inc. and owns shares of Anika Therapeutics, Inc. (ANIK) stock worth about $259.7K.
Signature
/s/ Patricia Walesiewicz, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow William R. Jellison and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • William R. Jellison has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $3,742,280.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: AVIENT CORP ($2,183,745).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of William R. Jellison

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AVNT AVIENT CORP Director $2,183,745 31 Mar 2026
MASI MASIMO CORP Director $740,486 +$437,940 +145% 11 Aug 2025
MDT Medtronic plc Director $558,372 +$462,750 +484% 27 Apr 2026
ANIK Anika Therapeutics, Inc. Director $259,677 20 Jun 2025

Insider Transactions Reported by William R. Jellison:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .